Invasive ventilation

INV_VENT

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Operations: NOMESCO codes — ^WX730 1 out of 7 registries used, show all original rules.	2783
4. Check minimum number of events None	2783
5. Include endpoints None	2783
6. Filter based on genotype QC (FinnGen only)	2783

Control definitions (FinnGen only)

Control exclude: COPD_INSUFFICIENCY

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	INV_VENT
CONTROL_EXCLUDE	COPD_INSUFFICIENCY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM	^WX730
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Invasive ventilation based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	25367	9923	15221
Only index persons	19618	7776	11842
Unadjusted period prevalence (%)
Whole population	0.37	0.28	0.43
Only index persons	0.39	0.29	0.45
Median age at first event (years)
Whole population	59.98	59.89	59.96
Only index persons	62.22	62.50	62.04

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2783	1150	1633
Unadjusted period prevalence (%)	0.58	0.39	0.72
Median age at first event (years)	62.96	59.29	65.55

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2528: Matched controls
25280

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Z3231

NOMESCO Finland

Registered nurse

5.4

323.0

1383

4622

ZXD05

NOMESCO Finland

Urgent procedure

6.1

323.0

1539

5133

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

20.7

323.0

1700

2282

Z2221

NOMESCO Finland

Medical doctor

6.4

323.0

1443

4327

TPH07

NOMESCO Finland

Cathetrisation of artery

17.4

323.0

1261

1367

WX704

NOMESCO Finland

Intubation

18.5

323.0

954

800

WX730

NOMESCO Finland

Conventional respirator

+∞

323.0

2528

WX892

NOMESCO Finland

Monitored bed care

16.5

323.0

981

936

TKC20

NOMESCO Finland

Catheterisation of bladder

13.8

323.0

842

883

Z3226

NOMESCO Finland

Physiotherapist

6.2

320.6

1087

2756

ZXE00

NOMESCO Finland

One hour or less

5.1

314.8

1649

6814

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

11.2

310.3

634

731

R4110

NOMESCO Finland

Physiotherapy

5.3

309.0

1292

4152

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

6.2

303.9

994

2375

XF400

NOMESCO Finland

ECG with 12 standard connections

5.9

291.9

1012

2575

TPH04

NOMESCO Finland

Cathetrisation of vein

5.3

275.6

1075

3096

ZXE10

NOMESCO Finland

More than one and less than three hours

4.5

271.3

1494

6118

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

5.8

267.2

917

2260

WX722

NOMESCO Finland

PEEP

12.1

255.0

495

500

AA1AD

NOMESCO Finland

CT of head and brain

4.7

253.7

1150

3808

Z2446

NOMESCO Finland

Social worker

8.6

246.5

586

854

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

28.1

224.6

312

126

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

13.3

213.4

392

345

T36

ICD-10 Finland

Poisoning by systemic antibiotics

12.6

212.8

401

373

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

16.0

211.1

356

256

WX408

NOMESCO Finland

General anesthesy, balanced

4.0

207.1

1138

4302

WX882

NOMESCO Finland

High dependency care

12.2

205.7

394

378

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

4.6

204.5

879

2634

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.0

199.1

1068

3919

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

27.6

198.7

277

112

ZXE20

NOMESCO Finland

More than three and less than five hours

4.9

192.2

746

1992

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.4

183.2

1526

7812

ZX120

NOMESCO Finland

Intravenous

5.7

170.4

550

1175

WX404

NOMESCO Finland

Intravenous generell anesthesy

3.8

159.6

856

3013

J96.0

ICD-10 Finland

Acute respiratory failure

27.5

159.4

222

ZXD10

NOMESCO Finland

Scheduled procedure

3.0

148.1

1314

6641

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

5.3

147.8

506

1141

5CM18

NOMESCO Finland

81.5

136.1

153

GBB00

NOMESCO Finland

Tracheostomy

21.0

135.5

205

106

C03CA01

ATC

furosemide; systemic

3.0

130.5

1043

4788

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

6.1

127.0

375

699

UGC12

NOMESCO Finland

Flexible bronchoscopy

5.2

123.7

425

948

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

6.0

119.8

359

679

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

13.5

118.7

213

171

R56.8

ICD-10 Finland

Other and unspecified convulsions

6.3

118.0

337

599

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

6.6

117.2

325

555

TK800

NOMESCO Finland

Hemodialysis

12.2

116.9

220

196

I50.9

ICD-10 Finland

Heart failure, unspecified

3.6

110.9

592

1986

WX890

NOMESCO Finland

Intesive care monitoring

30.7

109.8

148

C07AB07

ATC

bisoprolol; oral

2.6

109.8

1431

8526

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

5.1

108.9

374

826

WX872

NOMESCO Finland

Intensive care

6.2

106.9

310

559

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.5

105.8

579

1970

R4120

NOMESCO Finland

Occupational therapy

5.1

99.9

342

749

N17.9

ICD-10 Finland

Acute renal failure, unspecified

6.9

99.1

264

423

N05AH04

ATC

quetiapine; oral

3.3

98.9

593

2153

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

5.9

98.4

297

561

WX002

NOMESCO Finland

Sedation and analgesia

2.9

96.3

705

2932

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

5.9

93.8

282

529

WX402

NOMESCO Finland

General anaesthesia

3.1

93.6

619

2397

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

5.1

89.8

307

668

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

5.9

89.1

268

502

N05AH03

ATC

olanzapine; systemic

5.3

88.5

292

610

WX725

NOMESCO Finland

Noninvasive ventilation

6.2

88.5

254

448

I50.0

ICD-10 Finland

Congestive heart failure

4.3

88.1

356

920

X57

ICD-10 Finland

Unspecified privation

9.3

87.9

190

219

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

4.1

87.2

382

1064

J96.1

ICD-10 Finland

Chronic respiratory failure

20.0

82.6

126

WW500

NOMESCO Finland

Blood transfusion

6.0

82.5

243

442

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.3

82.5

338

882

ZXE40

NOMESCO Finland

More than seven and less than nine hours

8.5

80.5

183

229

N03AX14

ATC

levetiracetam; systemic

7.8

79.5

191

261

Z2445

NOMESCO Finland

Psychologist

5.9

77.3

229

419

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.4

76.8

426

1430

ZXA05

NOMESCO Finland

Left side

2.5

76.7

802

4013

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.5

76.6

740

3549

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.7

75.6

278

649

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

3.5

74.3

388

1243

ZXD35

NOMESCO Finland

Usual procedure

6.5

74.1

202

331

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

6.3

73.6

206

350

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

6.9

73.3

192

298

WX302

NOMESCO Finland

Thoracal epidural anesthesy

4.8

70.9

256

585

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

11.1

70.7

138

131

WX930

NOMESCO Finland

Thepapeutic hypothermia

89.4

70.3

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

5.8

69.5

209

388

ZXA00

NOMESCO Finland

Right side

2.3

69.2

819

4322

A41.9

ICD-10 Finland

Sepsis, unspecified

5.6

68.9

212

405

X59

ICD-10 Finland

Exposure to unspecified factor

2.6

68.8

600

2695

TK810

NOMESCO Finland

Hemofiltration

23.1

67.5

ZY000

NOMESCO Finland

Hospital inpatient

13.2

67.5

121

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.7

67.2

179

284

XA400

NOMESCO Finland

EEG

30.0

66.8

G40.9

ICD-10 Finland

Epilepsy, unspecified

6.1

66.6

192

338

N03AG01

ATC

valproic acid; systemic, rectal

4.3

65.8

266

679

WX900

NOMESCO Finland

Resuscitation

26.9

65.6

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.1

65.5

415

1522

B01AA03

ATC

warfarin; systemic

2.4

65.1

669

3269

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

7.1

64.6

164

243

Z3229

NOMESCO Finland

Other healthcare associate professional

3.3

64.3

357

1190

JN4BD

NOMESCO Finland

Extensive body CT

3.0

63.9

411

1521

N05BA01

ATC

diazepam; systemic, rectal

2.9

63.4

452

1788

XA800

NOMESCO Finland

Neuropsychological investigation

4.9

62.4

218

480

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

62.1

842

4684

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

10.0

61.3

126

132

JN3AD

NOMESCO Finland

Abdominal CT examination

3.5

61.1

309

956

N07BB01

ATC

disulfiram; oral

4.8

60.9

216

483

ZY010

NOMESCO Finland

Hospital outpatient

4.6

60.3

223

520

N05AA02

ATC

levomepromazine; systemic

5.0

60.3

205

438

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

5.2

60.1

198

408

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.4

60.0

315

1003

F10.25

ICD-10 Finland

Alcohol dependence continuous use

8.9

59.7

131

154

TPX10

NOMESCO Finland

Implantation of vascular injection port

6.2

59.4

167

284

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

5.9

58.6

171

305

WW804

NOMESCO Finland

Transfer from treating institution to higher-Level care, accompanied by doctor

36.8

58.5

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

4.1

57.7

242

637

R40.2

ICD-10 Finland

Coma, unspecified

15.5

57.6

B01AB10

ATC

tinzaparin; parenteral

3.7

57.1

272

800

F29

ICD-10 Finland

Unspecified nonorganic psychosis

5.9

57.1

167

299

A06AD11

ATC

lactulose; oral

2.6

56.6

486

2135

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

8.0

55.8

131

172

JDB10

NOMESCO Finland

Percutaneous gastrostomy

10.8

55.4

109

105

A28

ICPC

Limited function/disability NOS

2.6

55.4

486

2155

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

9.1

54.9

119

137

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

4.5

54.5

204

481

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

11.6

53.9

102

A02BC02

ATC

pantoprazole; systemic

1.9

53.9

1625

12167

RS220

NOMESCO Finland

10.3

53.6

108

109

G41.9

ICD-10 Finland

Status epilepticus, unspecified

18.8

53.0

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.4

52.7

280

896

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

10.1

52.6

107

110

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.9

52.6

353

1332

A46

ICD-10 Finland

Erysipelas

2.6

52.6

454

1992

C03DA01

ATC

spironolactone; oral

2.8

52.4

371

1448

XF612

NOMESCO Finland

Measurement of central venous pressure

68.1

52.4

C09AA05

ATC

ramipril; oral

2.1

52.3

734

4081

F10.09

ICD-10 Finland

Alcohol intoxication UNS

7.0

52.0

133

199

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.1

51.5

700

3833

TQW11

NOMESCO Finland

Vacuum treatment of wound

7.4

51.0

126

179

JAH00

NOMESCO Finland

Laparotomy

5.9

51.0

148

262

WX110

NOMESCO Finland

Local anesthesy

1.9

50.8

1678

12836

J01MA12

ATC

levofloxacin; systemic

2.3

50.7

575

2896

N05CF01

ATC

zopiclone; oral

2.0

50.7

878

5304

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.1

50.3

210

549

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.1

49.9

686

3768

N06AX11

ATC

mirtazapine; oral

2.0

49.6

829

4931

R03BB04

ATC

tiotropium bromide; inhalant

2.9

49.3

334

1265

F10.20

ICD-10 Finland

Alcohol dependence currently independent

7.1

49.2

125

185

XX3DW

NOMESCO Finland

Time consuming IT work

2.8

48.9

342

1318

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

3.2

48.9

275

917

ZXE90

NOMESCO Finland

More than 22 hours

14.2

48.8

XF600

NOMESCO Finland

Bloodpressure measurement

3.3

48.4

260

837

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.2

48.3

276

930

RS221

NOMESCO Finland

8.3

48.3

110

138

R06.0

ICD-10 Finland

Dyspnoea

2.1

48.1

684

3802

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.8

48.0

337

1301

ZX122

NOMESCO Finland

Intra-arterial

32.3

47.8

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

6.4

47.7

130

212

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.7

47.0

352

1415

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.7

46.8

221

642

N03AX16

ATC

pregabalin; oral

2.1

45.9

630

3434

N02AX02

ATC

tramadol; systemic, rectal

1.9

45.7

1094

7368

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

8.5

45.6

102

124

1CX08

NOMESCO Finland

23.8

45.5

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

4.5

44.9

167

390

N03AX09

ATC

lamotrigine; oral

4.2

44.8

181

458

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

44.8

802

4854

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

6.0

44.8

129

226

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

5.8

44.8

131

234

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

6.8

44.5

116

178

ZZA00

NOMESCO Finland

Split skin graft

4.9

44.5

152

325

N06AB04

ATC

citalopram; systemic

2.1

44.5

576

3057

N05AX12

ATC

aripiprazole; systemic

4.7

43.6

154

341

B01AB05

ATC

enoxaparin; parenteral

1.9

43.5

804

4918

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

4.6

43.4

159

366

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4.1

43.2

179

464

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

8.5

42.9

117

AA5PD

NOMESCO Finland

CT examination of brain pefusion

14.1

42.4

J96.9

ICD-10 Finland

Respiratory failure, unspecified

20.8

42.3

P15

ICPC

Chronic alcohol abuse

5.3

42.3

135

268

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.5

42.2

363

1574

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

3.2

42.2

243

820

GD1AD

NOMESCO Finland

Thorax CT examination

4.1

42.2

174

449

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.1

42.2

251

868

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

6.7

42.0

110

170

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

7.6

42.0

101

138

AA1BD

NOMESCO Finland

Extensive CT of head and brain

5.6

41.9

126

233

N06AX16

ATC

venlafaxine; oral

2.5

41.6

372

1645

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

10.4

41.3

EBA15

NOMESCO Finland

Extraction of large number of teeth

4.1

41.2

167

424

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

3.7

40.8

187

529

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

3.2

40.8

236

799

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

14.4

40.5

I50.1

ICD-10 Finland

Left ventricular failure

3.6

40.4

191

555

B18.2

ICD-10 Finland

Chronic viral hepatitis C

11.9

40.3

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.9

40.2

263

967

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.4

39.6

208

656

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.5

39.6

333

1423

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.6

39.6

120

224

WW200

NOMESCO Finland

Immunization

5.2

39.6

128

258

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

20.1

39.2

F10.24

ICD-10 Finland

Alcohol depence active use

7.4

38.9

133

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.1

38.8

235

819

RD210

NOMESCO Finland

6.6

38.8

102

159

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.2

38.7

223

751

TJD20

NOMESCO Finland

Change of gastrostomy tube

16.7

38.6

N05BA04

ATC

oxazepam; oral

2.0

38.6

634

3678

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

6.3

38.5

105

172

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

6.1

38.4

108

184

C08CA01

ATC

amlodipine; oral

1.8

38.3

923

6121

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

14.5

38.3

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

8.6

37.6

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

9.8

37.5

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

12.4

37.5

A10AE04

ATC

insulin glargine; parenteral

2.6

37.3

301

1255

J01FF01

ATC

clindamycin; systemic

1.9

37.2

698

4243

RS222

NOMESCO Finland

8.6

37.1

N05CD07

ATC

temazepam; oral

2.3

37.1

376

1765

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.5

37.1

183

550

N05AF03

ATC

chlorprothixene; systemic

5.1

36.5

118

238

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

8.3

36.3

102

G93.1

ICD-10 Finland

Anoxic brain damage, not elsewhere classified

18.4

36.2

N03AF02

ATC

oxcarbazepine; oral

4.3

35.9

138

333

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.2

35.8

198

649

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

5.7

35.8

106

193

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

6.0

35.6

101

174

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

11.9

35.6

N02AA05

ATC

oxycodone; systemic

2.2

35.6

419

2111

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.7

35.6

162

456

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

11.1

35.4

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

6.8

35.3

138

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

11.7

35.3

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.7

35.2

251

974

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.2

35.1

113

227

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.8

34.9

157

437

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

6.1

34.9

167

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.0

34.9

145

377

Z49.1

ICD-10 Finland

Extracorporeal dialysis

7.5

34.5

114

D64.9

ICD-10 Finland

Anaemia, unspecified

2.4

34.4

322

1451

R4130

NOMESCO Finland

Speech therapy

4.7

34.4

120

263

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.6

34.0

159

457

JN4AD

NOMESCO Finland

Body CT examination

2.7

34.0

253

1005

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.9

33.9

622

3727

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

3.3

33.9

181

578

IAB08

NOMESCO Finland

Consultation concerning a patient who has attempted suicide

27.5

33.7

N05AX08

ATC

risperidone; systemic

2.7

33.7

251

997

P16

ICPC

Acute alcohol abuse

6.6

33.5

137

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.4

33.3

323

1480

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

8.6

33.2

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

8.3

33.0

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.8

32.8

800

5261

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

6.6

32.6

135

ZXA10

NOMESCO Finland

Bilateral

2.0

32.5

496

2771

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.8

32.1

217

812

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

8.1

32.1

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.7

31.9

112

247

F61.0

ICD-10 Finland

Mixed personality disorders

6.9

31.8

121

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

5.1

31.4

102

207

WX419

NOMESCO Finland

Other general anesthesy

8.3

31.3

L28

ICPC

Limited function/disability (L)

2.1

31.2

417

2207

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

28.4

31.1

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.5

30.9

152

455

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

9.5

30.9

I50

ICD-10 Finland

Heart failure

4.2

30.8

122

303

XF404

NOMESCO Finland

Ambulatory ECG

2.4

30.7

281

1248

F60.9

ICD-10 Finland

Personality disorder, unspecified

7.4

30.7

102

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

7.4

30.7

102

IGY02

NOMESCO Finland

Psychiatric monitoring contact

5.7

30.7

162

A11CC03

ATC

alfacalcidol; systemic

4.9

30.7

104

221

PA4AC

NOMESCO Finland

Vertebralis angiography with X-ray

36.0

30.6

TAB00

NOMESCO Finland

Lumbar puncture

3.4

30.4

154

472

K92.0

ICD-10 Finland

Haematemesis

4.7

30.4

107

237

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.1

30.2

361

1821

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.8

30.0

130

351

ZX108

NOMESCO Finland

Inhalation

10.4

29.9

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

16.5

29.3

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

11.0

29.3

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

10.6

29.2

ZXH02

NOMESCO Finland

Procedure performed inside intensive care unit

57.4

29.1

R4150

NOMESCO Finland

Neuropsychological rehabilitation

11.5

28.8

R4190

NOMESCO Finland

Nutritional therapy

3.5

28.8

139

410

R1260

NOMESCO Finland

Evaluation of communicative skills

5.3

28.8

175

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

5.0

28.8

192

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.6

28.8

230

950

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

7.6

28.6

L89

ICD-10 Finland

Decubitus ulcer and pressure area

5.9

28.6

140

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.7

28.6

211

832

Z71.8

ICD-10 Finland

Other specified counselling

1.8

28.6

574

3518

RS230

NOMESCO Finland

12.7

28.6

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

5.4

28.5

165

H02AB07

ATC

prednisone; oral

2.1

28.4

375

1967

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

4.8

28.3

209

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

8.8

28.2

N05BA06

ATC

lorazepam; systemic, sublingual

3.0

28.2

168

579

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

15.6

28.1

J01MA14

ATC

moxifloxacin; systemic

2.4

27.9

249

1090

T51.0

ICD-10 Finland

Toxic effect: Ethanol

15.1

27.8

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

6.0

27.7

134

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

5.0

27.6

188

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

27.5

209

838

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.5

27.5

227

953

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

27.5

1168

8847

N06AB10

ATC

escitalopram; oral

1.9

27.4

455

2608

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.5

27.3

229

970

M04AA01

ATC

allopurinol; systemic

2.0

27.1

373

1988

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

3.1

27.1

153

507

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

3.0

27.1

166

583

N05AH02

ATC

clozapine; systemic

5.7

27.1

142

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

22.0

26.9

AN1

Coronary angiography

2.1

26.9

342

1764

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

7.5

26.9

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

7.0

26.8

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

3.7

26.7

120

334

KA1AE

NOMESCO Finland

Kidney ultrasound examination

4.2

26.7

104

255

AAF00

NOMESCO Finland

Ventriculostomy

12.9

26.6

3AC01

NOMESCO Finland

7.7

26.5

R53

ICD-10 Finland

Malaise and fatigue

1.8

26.5

508

3053

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

8.6

26.5

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

14.9

26.5

SPAT1265

SPAT

Breathalyser

8.1

26.4

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.8

26.3

176

654

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

8.9

26.2

G41.0

ICD-10 Finland

Grand mal status epilepticus

26.0

26.2

A02BC01

ATC

omeprazole; systemic

1.7

26.1

679

4493

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

4.0

26.0

107

276

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

26.0

675

4459

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.7

25.9

184

709

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.9

25.8

180

S97

ICPC

Chronic ulcer skin

2.8

25.8

172

636

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

11.1

25.8

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.5

25.8

223

960

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

9.8

25.7

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

2.8

25.7

176

664

TFP20

NOMESCO Finland

Cardiodefibrillation

2.4

25.7

227

988

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.3

25.6

267

1260

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.4

25.6

223

962

B03XA02

ATC

darbepoetin alfa; parenteral

5.0

25.5

174

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.3

25.4

264

1244

N17.8

ICD-10 Finland

Other acute renal failure

6.6

25.4

102

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.6

25.4

190

755

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

4.0

25.2

103

264

P18

ICPC

Medication abuse

14.7

25.2

L04AA06

ATC

mycophenolic acid; systemic

5.7

25.1

131

XCK10

NOMESCO Finland

Photography of fundus of eye

2.2

25.0

282

1379

127

Kela drug reimbursment

Transplant complication

5.9

24.9

124

R50.9

ICD-10 Finland

Fever, unspecified

1.9

24.9

381

2110

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

2.6

24.9

193

782

B01AC04

ATC

clopidogrel; oral

1.9

24.9

434

2522

WX610

NOMESCO Finland

Patient controlled analgesia

11.7

24.9

R60.0

ICD-10 Finland

Localized oedema

2.1

24.9

292

1455

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.8

24.9

167

622

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

10.6

24.8

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

24.7

420

2418

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

6.9

24.6

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

6.4

24.6

103

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

24.5

1367

10933

N18.0

ICD-10 Finland

End-stage renal disease

6.2

24.4

108

FXG00

NOMESCO Finland

Insertion and use of IABP

20.3

24.3

J12.8

ICD-10 Finland

Other viral pneumonia

12.1

24.2

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

24.2

416

2405

N05BA02

ATC

chlordiazepoxide; systemic

4.0

24.2

255

Z72.2

ICD-10 Finland

Drug use

13.9

24.0

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

16.8

24.0

N05AB03

ATC

perphenazine; systemic, rectal

3.5

23.9

117

350

T65.9

ICD-10 Finland

Toxic effect: Toxic effect of unspecified substance

19.2

23.9

RS121

NOMESCO Finland

8.8

23.8

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

15.2

23.8

N06AB06

ATC

sertraline; oral

2.2

23.7

252

1199

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

5.4

23.6

137

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

5.1

23.6

154

RF220

NOMESCO Finland

5.6

23.6

125

S01.0

ICD-10 Finland

Open wound of scalp

2.3

23.5

222

999

C01AA05

ATC

digoxin; systemic

2.3

23.5

237

1101

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.9

23.4

263

N03AX18

ATC

lacosamide; systemic

9.1

23.3

N05AN01

ATC

lithium; oral

4.1

23.2

235

N03AF01

ATC

carbamazepine; oral, rectal

2.8

23.1

160

605

N18.8

ICD-10 Finland

Other chronic renal failure

3.6

23.1

106

301

A12AA04

ATC

calcium carbonate; oral

5.1

23.0

150

IGY99

NOMESCO Finland

Other psychiatric treatment contact

4.8

22.7

161

J01DB01

ATC

cefalexin; oral

1.6

22.6

1910

16675

RK320

NOMESCO Finland

7.6

22.6

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

19.1

22.6

SPAT1262

SPAT

Handing over of treatment supplies

1.8

22.6

468

2873

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

5.3

22.6

136

W19

ICD-10 Finland

Unspecified fall

2.2

22.5

254

1242

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

9.9

22.5

E87.2

ICD-10 Finland

Acidosis

11.9

22.5

F05.9

ICD-10 Finland

Delirium, unspecified

4.5

22.5

185

XX1XW

NOMESCO Finland

Extensive written report from radiologist

4.2

22.4

209

E87.5

ICD-10 Finland

Hyperkalaemia

5.0

22.4

146

P19

ICPC

Drug abuse

8.4

22.4

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.6

22.3

171

689

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.7

22.3

155

589

GBB03

NOMESCO Finland

Percutaneous tracheostomy

52.5

22.1

N19

ICD-10 Finland

Unspecified kidney failure

3.3

22.1

114

356

N05AA01

ATC

chlorpromazine; systemic, rectal

5.8

22.1

111

N03AE01

ATC

clonazepam; systemic

2.7

22.0

161

630

E86

ICD-10 Finland

Volume depletion

3.7

22.0

267

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.9

22.0

149

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.5

21.9

186

790

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.8

21.9

390

2276

AAA27

NOMESCO Finland

Insertion of intracerebral pressure monitoring device

63.1

21.9

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.7

21.8

274

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.4

21.8

197

866

E87.6

ICD-10 Finland

Hypokalaemia

3.5

21.8

103

300

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

21.7

694

4813

A10BA02

ATC

metformin; oral

1.6

21.7

668

4590

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

12.8

21.6

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.7

21.5

503

3195

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

3.7

21.5

262

K92.1

ICD-10 Finland

Melaena

2.6

21.4

164

660

5AB01

NOMESCO Finland

26.6

21.3

J45.1

ICD-10 Finland

Nonallergic asthma

2.4

21.3

185

795

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

5.8

21.2

105

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.3

21.0

110

347

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

5.8

21.0

106

ZXD08

NOMESCO Finland

16.7

20.9

N05BE01

ATC

buspirone; oral

3.8

20.9

238

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.2

20.9

110

349

ICC03

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric ward

24.4

20.8

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.6

20.8

152

596

N05AD01

ATC

haloperidol; systemic

3.4

20.8

103

312

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

5.0

20.7

137

ZYD04

NOMESCO Finland

Emergency outreach service, another specialty

30.3

20.6

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

6.6

20.5

Z94.0

ICD-10 Finland

Kidney transplant status

6.6

20.5

JN5BD

NOMESCO Finland

Head and body CT examination for trauma

7.8

20.5

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

13.6

20.5

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.5

20.5

169

710

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

5.5

20.4

114

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

22.5

20.4

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

20.3

332

1877

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.6

20.3

157

634

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.7

20.3

147

573

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

20.2

302

1653

H02AB06

ATC

prednisolone; systemic

1.5

20.2

1059

8214

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.6

20.1

154

620

T90.5

ICD-10 Finland

Sequelae of intracranial injury

5.9

19.9

GD1LA

NOMESCO Finland

5.0

19.9

130

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

4.0

19.8

209

TNG34

NOMESCO Finland

Major custom moulded orthopaedic cast, knee or lower leg

5.4

19.8

114

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.8

19.8

130

479

J86.9

ICD-10 Finland

Pyothorax without fistula

6.9

19.7

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

15.4

19.7

WW800

NOMESCO Finland

Transfer to other hospital with 1 staff member

74.1

19.7

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

5.9

19.6

ED1AA

NOMESCO Finland

Mandipular X-ray examination

9.0

19.6

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

4.1

19.6

192

K65.0

ICD-10 Finland

Acute peritonitis

6.0

19.5

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

21.8

19.5

ZXE70

NOMESCO Finland

Moren than 15 and less than 18 hours

21.8

19.5

AP1

Catheterization of the left side of the heart

4.5

19.4

156

A12BA01

ATC

potassium chloride; oral

2.7

19.4

138

531

N02BE01

ATC

paracetamol; systemic, rectal

1.6

19.4

1987

17720

205

Kela drug reimbursment

Chronic hypertension

1.6

19.4

689

4881

F31.8

ICD-10 Finland

Other bipolar affective disorders

4.9

19.4

130

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

2.8

19.3

127

468

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

2.5

19.2

151

617

Z72.1

ICD-10 Finland

Alcohol use

5.1

19.1

119

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.0

19.1

242

1241

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

5.4

19.0

107

B01AB04

ATC

dalteparin; parenteral

2.6

19.0

139

544

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

19.0

321

1835

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.4

18.9

173

765

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

10.7

18.9

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

5.5

18.9

104

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

6.5

18.8

WX320

NOMESCO Finland

Spinalanesthesy

1.6

18.8

517

3425

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.6

18.7

145

587

Y07

ICD-10 Finland

Other maltreatment

8.0

18.7

I42.0

ICD-10 Finland

Dilated cardiomyopathy

3.3

18.7

294

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.1

18.7

107

360

PA2AD

NOMESCO Finland

CT angiography of brain

10.4

18.6

JAH33

NOMESCO Finland

Opening of laparostomy

21.0

18.6

A41.8

ICD-10 Finland

Other specified sepsis

4.6

18.6

145

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

7.3

18.5

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

4.4

18.5

155

PD5BD

NOMESCO Finland

Extensive CT of aorta

4.2

18.4

174

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

4.5

18.4

151

C10AA01

ATC

simvastatin; oral

1.5

18.4

1015

7909

RK110

NOMESCO Finland

7.0

18.4

J81

ICD-10 Finland

Pulmonary oedema

8.8

18.4

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

3.5

18.4

250

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

5.2

18.3

112

F19.9

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder

19.5

18.2

C02AC05

ATC

moxonidine; oral

2.6

18.2

138

553

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

18.2

443

2837

N06AB03

ATC

fluoxetine; oral

1.9

18.1

285

1585

N03AB02

ATC

phenytoin; systemic

5.6

18.1

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

18.1

517

3455

I47.2

ICD-10 Finland

Ventricular tachycardia

3.7

18.1

222

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

5.2

18.0

110

S06.3

ICD-10 Finland

Focal brain injury

5.4

18.0

102

ZX070

NOMESCO Finland

Intensity modified radiotherapy

4.0

18.0

188

Z49.2

ICD-10 Finland

Other dialysis

8.1

18.0

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

5.5

18.0

F31

ICD-10 Finland

Bipolar affective disorder

5.6

18.0

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

3.1

18.0

100

331

NHQ40

NOMESCO Finland

Amputation of toe

4.2

17.9

165

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

16.6

17.8

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

6.7

17.8

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

17.8

406

2548

G72.8

ICD-10 Finland

Other specified myopathies

4.4

17.8

147

WZC30

NOMESCO Finland

Teaching

1.8

17.8

318

1849

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

7.9

17.8

XX3XW

NOMESCO Finland

7.9

17.8

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

20.2

17.7

I46.9

ICD-10 Finland

Cardiac arrest, unspecified

11.1

17.7

N05AE04

ATC

ziprasidone; systemic

8.9

17.6

WX212

NOMESCO Finland

Femoral plexus blockade

4.0

17.6

182

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

17.5

131

521

2BD01

NOMESCO Finland

15.7

17.5

R11

ICD-10 Finland

Nausea and vomiting

2.1

17.5

198

969

C07AA05

ATC

propranolol; systemic

1.7

17.4

398

2498

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

9.1

17.4

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

9.6

17.4

S06.2

ICD-10 Finland

Diffuse brain injury

5.8

17.4

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

17.3

495

3303

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

7.1

17.3

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

17.3

183

869

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

12.1

17.3

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

4.8

17.3

120

3A064

NOMESCO Finland

14.0

17.3

A02BC05

ATC

esomeprazole; systemic

1.5

17.3

865

6582

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.8

17.3

N06AX21

ATC

duloxetine; oral

2.0

17.2

234

1233

J46

ICD-10 Finland

Status asthmaticus

3.4

17.0

244

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

17.0

292

1673

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

8.7

16.9

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

5.6

16.9

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.7

16.9

119

456

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

6.0

16.8

XG466

NOMESCO Finland

Sleep oxymetry

3.0

16.7

330

T40.9

ICD-10 Finland

Poisoning: Other and unspecified psychodysleptics [hallucinogens]

63.7

16.7

R4140

NOMESCO Finland

Psychotherapy

8.1

16.7

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

16.7

514

3492

GBB13

NOMESCO Finland

Revision of tracheostomy

35.3

16.7

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

4.8

16.7

116

J80

ICD-10 Finland

Adult respiratory distress syndrome

12.7

16.6

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.1

16.6

196

975

ZXY60

NOMESCO Finland

2-person team, nurses

8.3

16.5

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

4.1

16.5

159

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

5.5

16.5

ZXY49

NOMESCO Finland

Other health care provider

10.1

16.4

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

4.3

16.4

141

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

4.5

16.3

132

ZXE92

NOMESCO Finland

2-3 days

40.3

16.3

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.2

16.3

280

I25.2

ICD-10 Finland

Old myocardial infarction

2.1

16.3

202

1023

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

6.7

16.3

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

14.3

16.3

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

3.8

16.2

181

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

8.4

16.2

JN4CD

NOMESCO Finland

Very extensive body CT

2.6

16.2

116

451

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

10.4

16.2

Z72.0

ICD-10 Finland

Tobacco use

3.6

16.2

212

WNF00

NOMESCO Finland

Infection source and contact determination

9.3

16.1

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

5.1

16.1

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

7.9

16.0

N04AA02

ATC

biperiden; systemic

3.9

16.0

168

F34.1

ICD-10 Finland

Dysthymia

3.1

16.0

295

P29

ICPC

Psychological sympt/compl other

2.5

16.0

128

528

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

6.5

16.0

S72.0

ICD-10 Finland

Fracture of neck of femur

2.8

15.9

103

377

UJC01

NOMESCO Finland

Scopy of lower throat

5.2

15.9

T05

ICPC

Feeding problem of adult

7.8

15.8

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

7.8

15.8

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

14.6

15.8

I25

ICD-10 Finland

Chronic ischaemic heart disease

2.4

15.8

141

615

R41.0

ICD-10 Finland

Disorientation, unspecified

2.9

15.8

327

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

3.9

15.7

166

ZXD20

NOMESCO Finland

Day surgery

1.8

15.7

285

1664

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.4

15.7

133

N05BA12

ATC

alprazolam; oral

1.9

15.7

230

1247

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

10.5

15.7

WX213

NOMESCO Finland

Lower leg blockade

6.5

15.7

V01.9

ICD-10 Finland

Pedestrian injured in collision with pedal cycle, Unspecified whether traffic or nontraffic accident

9.2

15.7

207

Kela drug reimbursment

Chronic arrhythmias

1.7

15.6

347

2157

PA7ST

NOMESCO Finland

Extensive medical infusion to cerebral artery

+∞

15.6

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

17.3

15.6

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

5.2

15.6

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

3.0

15.6

306

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

26.4

15.6

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

4.9

15.5

103

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

4.4

15.5

130

WX870

NOMESCO Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3020779) Urea [Moles/volume] in Serum or Plasma

844

2191

5.09

311.27

11.7

7.8

mmol/l

10.2

10.0

0.20

799

2085

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

752

1634

5.94

307.65

14.3

8.4

mmol/l

25.2

24.5

3.78

728

1627

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1192

3698

4.89

307.65

6.5

3.7

mmol/l

0.8

3.60

1120

3466

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1059

3170

4.78

307.65

9.9

6.3

mmol/l

1.1

0.11

990

2943

(3012501) Base excess in Blood by calculation

394

496

9.09

298.78

9.0

4.1

mmol/l

3.2

2.6

2.66

303

321

(3013290) Carbon dioxide [Partial pressure] in Blood

394

496

9.09

298.78

9.0

4.1

kpa

5.2

5.0

3.78

371

489

(3027315) Oxygen [Partial pressure] in Blood

394

497

9.07

298.28

9.0

4.1

kpa

8.7

8.6

0.47

371

489

(3023368) Bacteria identified in Blood by Culture

1524

6399

4.05

290.33

9.2

4.3

—

(3010421) pH of Blood

406

591

7.87

271.71

9.1

3.8

7.4

0.14

371

489

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

561

1208

5.56

253.45

16.6

9.4

mmol/l

24.4

24.2

0.51

525

1131

(3033658) Prothrombin time (PT) actual/Normal

1368

5744

3.72

251.77

8.7

4.1

81.4

87.6

14.44

1339

5611

(3018418) pH of Serum or Plasma

1458

6495

3.61

242.41

8.0

4.0

7.4

0.28

459

1234

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

797

2386

4.28

238.55

6.4

3.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

353

541

7.33

224.31

3.3

2.8

umol/l

36.4

36.6

0.03

295

463

(3026782) Osmolality of Urine

1144

4559

3.56

222.81

4.2

2.8

mosm/kgh2o

506.8

557.2

14.13

1017

3878

(1616796) Gas panel - Central venous blood

330

501

7.34

211.20

7.6

3.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

706

2108

4.15

209.51

14.9

7.0

mmol/l

1.5

1.4

0.36

664

2017

(3000991) Gas panel - Venous blood

711

2135

4.13

209.33

17.2

8.2

—

(40767503) Oxygen content in Capillary blood by calculation

322

481

7.44

209.09

4.2

2.4

15.8

16.1

0.30

149

250

(36304419) Bacteria [Presence] in Urine

1361

6236

3.31

208.00

5.3

3.2

—

(3003396) Base excess in Arterial blood by calculation

804

2648

3.86

207.30

16.8

7.4

mmol/l

1.2

1.0

0.58

670

2047

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

802

2645

3.85

206.26

16.7

7.4

kpa

5.3

5.1

7.51

744

2514

(3028271) Lactate [Moles/volume] in Capillary blood

279

359

8.53

206.08

2.8

1.9

mmol/l

1.8

1.7

0.48

248

352

(3018677) aPTT in Platelet poor plasma by Coagulation assay

973

3649

3.56

205.84

3.4

2.5

31.1

30.1

3.27

953

3546

(3027801) Oxygen [Partial pressure] in Arterial blood

801

2646

3.85

205.42

16.7

7.4

kpa

12.3

0.10

745

2518

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

541

1338

4.78

205.19

7.0

4.7

mmol/l

24.2

23.9

1.20

501

1210

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

369

660

6.29

201.33

2.8

1.7

—

(3030467) Casts [#/volume] in Urine by Automated count

1360

6406

3.20

195.18

5.3

3.3

e6/l

0.8

0.4

3.22

1127

4883

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

403

813

5.63

193.37

4.3

u/ml

0.3

0.4

2.92

249

462

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

318

516

6.83

190.74

1.7

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

318

516

6.83

190.74

1.7

1.3

—

(3042936) Bacteria identified in Isolate by Culture

862

3177

3.48

184.68

3.3

2.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

765

2636

3.62

181.74

2.4

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

761

2615

3.63

181.53

2.4

1.7

—

(3002582) Erythrocytes [#/volume] in Urine

1409

7006

3.05

179.87

5.5

3.4

e6/l

143.4

95.5

0.31

1171

5439

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

742

2531

3.63

178.72

3.9

3.0

umol/l

8.7

8.6

0.01

628

2218

(3000850) Epithelial cells [#/volume] in Urine

1107

4882

3.10

173.84

4.4

2.6

e6/l

6.3

5.0

1.75

1011

4303

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

647

2150

3.62

160.58

2.9

2.3

g/l

0.2

2.47

581

2007

(3021589) Normoblasts [#/volume] in Blood

1717

9919

2.91

159.57

21.3

9.6

e9/l

0.0

0.02

1424

8044

(3007853) Bacteria identified in Skin by Aerobe culture

740

2692

3.38

159.11

2.5

1.7

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1753

10269

2.91

158.10

17.5

6.4

mmol/l

1.2

30.54

1653

9288

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1357

7077

2.79

151.09

5.0

3.2

u/l

52.6

36.8

1.12

1259

6728

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

331

697

5.25

150.13

3.8

3.6

g/l

3.5

0.07

321

668

(4198724)

125

17.17

150.00

2.2

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

456

1256

4.15

147.69

21.4

10.5

—

(3018095) Leukocytes [#/volume] in Urine

1461

8064

2.71

143.08

6.4

3.8

e6/l

135.0

105.2

0.39

1185

5800

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

598

2034

3.47

141.66

3.3

2.4

u/l

37.5

62.8

0.54

512

1732

(42870588) Differential panel, method unspecified - Blood

1415

7733

2.69

140.66

8.5

6.0

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1644

9683

2.71

140.21

9.3

5.0

g/l

31.5

35.3

84.58

1542

9010

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

878

3777

2.94

138.90

2.5

1.8

—

(3016502) Oxygen saturation in Arterial blood

650

2386

3.25

135.52

19.1

7.9

95.2

95.6

0.64

623

2289

(40758558) Short blood count panel - Blood

1136

5682

2.69

133.34

10.7

6.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

505

1604

3.62

132.38

2.2

1.6

—

(3032080) INR in Blood by Coagulation assay

1582

9324

2.61

131.78

16.9

9.8

inr

1.2

1.3

1.77

665

2633

(3028707) Methadone [Presence] in Urine by Screen method

199

291

7.29

130.65

4.1

2.9

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

333

793

4.63

129.79

3.2

2.4

ug/l

1312.1

527.0

0.91

317

747

(3014576) Chloride [Moles/volume] in Serum or Plasma

727

2912

3.03

129.78

16.7

6.8

mmol/l

104.3

104.4

0.05

709

2838

(3002173) Hemoglobin [Mass/volume] in Arterial blood

606

2193

3.25

128.81

19.3

8.3

g/l

115.0

121.9

11.80

586

2104

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1807

11586

2.60

122.45

10.0

6.2

umol/l

12.2

12.7

0.70

1726

10971

(3012544) pH of Venous blood

639

2454

3.08

122.12

6.6

4.4

7.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

146

161

9.52

121.01

1.9

1.4

promille

1.8

1.2

2.77

124

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

740

3124

2.86

118.76

4.1

2.6

20.2

23.0

5.53

663

2677

(3002032) Base excess in Venous blood by calculation

621

2385

3.06

118.32

6.7

4.3

mmol/l

2.0

1.7

0.78

502

1869

(3036489) Thrombin time

338

879

4.24

117.18

2.9

2.8

22.5

22.0

0.54

321

788

(3021447) Carbon dioxide [Partial pressure] in Venous blood

619

2394

3.04

116.31

6.7

4.3

kpa

6.0

5.8

4.18

577

2314

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

178

266

7.08

114.39

2.1

1.7

—

(3022096) Basophils/100 leukocytes in Blood

1630

10190

2.45

112.97

9.7

6.2

0.5

0.7

14.94

1552

9517

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

508

1798

3.23

110.78

9.7

3.7

mmol/l

1.2

17.28

467

1556

(3004789) Transferrin [Mass/volume] in Serum or Plasma

753

3333

2.73

109.20

4.0

2.5

g/l

2.2

2.3

5.29

700

3091

(3006504) Eosinophils/100 leukocytes in Blood

1649

10489

2.40

108.00

9.8

6.1

2.5

2.9

10.05

1572

9777

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1734

11295

2.42

107.28

17.0

7.1

mmol/l

1.2

22.97

1361

9548

(3019069) Monocytes/100 leukocytes in Blood

1652

10542

2.40

107.02

9.9

6.4

8.8

0.18

1576

9874

(40761536) Microorganisms panel - Urine sediment

512

1868

3.13

105.71

6.5

3.9

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

295

750

4.28

105.05

3.5

4.0

82.7

90.0

4.58

288

714

(3022948) Iron [Moles/volume] in Serum or Plasma

781

3612

2.62

102.87

3.9

2.5

umol/l

10.7

13.1

14.18

727

3352

(3026008) Bacteria identified in Urine by Culture

1162

6462

2.37

102.12

4.2

3.1

—

(3052851) Hemolysis interference index of Serum or Plasma

273

669

4.42

101.92

5.1

3.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

226

475

5.09

101.82

1.6

1.5

—

(3002030) Lymphocytes/100 leukocytes in Blood

1660

10809

2.33

99.78

9.8

6.2

23.2

27.9

46.40

1583

10082

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

270

668

4.37

99.50

3.5

3.0

223.8

185.2

7.28

258

639

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

889

4464

2.46

97.49

5.2

3.8

ng/l

566.9

685.5

0.19

779

3592

(3024891) Influenza virus A+B Ag [Presence] in Specimen

256

621

4.44

96.71

1.5

1.2

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1186

6786

2.30

96.03

3.2

2.2

u/l

392.8

250.6

1.67

1120

6370

(3013826) Glucose [Moles/volume] in Serum or Plasma

1918

13418

2.38

95.44

13.4

4.9

mmol/l

7.1

6.8

8.56

1831

12573

(3024928) Oxygen saturation in Venous blood

227

507

4.79

95.04

3.9

3.8

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

183

340

5.69

94.50

2.0

1.6

—

(3018010) Neutrophils/100 leukocytes in Blood

1618

10644

2.24

91.77

9.7

6.0

61.2

57.0

31.14

1545

9972

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

11.27

89.66

2.2

3.3

umol/l

347.3

104.7

2.30

(3001604) Monocytes [#/volume] in Blood

1658

11127

2.21

87.95

9.5

5.8

e9/l

0.7

0.6

21.64

1434

9538

(3024354) Oxygen [Partial pressure] in Venous blood

504

2009

2.84

87.57

5.9

3.8

kpa

5.1

4.7

3.58

461

1937

(3006184) Hemoglobin [Mass/volume] in Capillary blood

216

497

4.63

87.06

3.8

2.1

g/l

124.9

128.5

0.93

163

376

(3006315) Basophils [#/volume] in Blood

1660

11176

2.20

86.93

9.5

5.9

e9/l

0.0

1.39

1436

9583

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

169

323

5.51

84.54

8.5

7.3

mg/l

11.6

11.7

0.13

158

303

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

112

140

8.29

83.90

2.8

1.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

218

531

4.37

81.66

4.2

2.2

—

(3019198) Lymphocytes [#/volume] in Blood

1670

11432

2.15

81.62

9.7

5.9

e9/l

1.8

2.0

3.04

1487

9994

(3044640) Blood type and Crossmatch panel - Blood

1178

7084

2.15

80.58

4.0

2.6

—

(3013115) Eosinophils [#/volume] in Blood

1677

11546

2.14

80.11

10.8

6.1

e9/l

0.2

1.52

1488

10050

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

136

223

6.36

79.74

2.3

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

121

176

7.14

79.48

2.1

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

738

3707

2.35

78.24

4.2

3.1

e6/l

2.6

1.8

1.75

412

2069

(3017143) Hepatitis C virus Ab [Presence] in Serum

532

2304

2.62

77.85

2.0

1.6

—

(3019060) Gas panel - Arterial blood

399

1496

2.95

77.01

10.4

5.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

183

415

4.65

74.94

2.1

1.7

—

(3016879) Cocaine [Presence] in Urine

228

621

3.91

73.28

4.6

2.2

—

(3021901) Oxygen saturation in Capillary blood

185

436

4.47

72.16

6.0

2.8

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

226

624

3.85

71.21

7.3

3.3

mmol/l

24.9

24.6

0.41

211

545

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

123

8.05

70.40

1.8

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

678

3427

2.29

69.80

2.3

1.8

—

(3023419) Bacteria identified in Sputum by Culture

141

273

5.39

69.42

2.2

2.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1777

12900

2.04

68.60

15.8

8.9

e9/l

4.9

4.1

21.77

1558

11189

(3021879) Hepatitis B virus core Ab [Presence] in Serum

377

1468

2.81

67.39

1.5

1.4

—

(3027944) Amphetamines [Presence] in Urine

229

663

3.67

67.27

4.7

2.1

—

(3000764) Benzodiazepines [Presence] in Urine

230

669

3.66

67.09

4.6

2.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

237

708

3.57

66.40

8.0

6.1

mg/l

1.8

1.5

4.23

220

657

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

124

7.72

65.92

1.9

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

213

598

3.77

65.42

1.4

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

187

480

4.10

65.13

2.2

1.7

—

(3028300) Cannabinoids [Presence] in Urine

229

678

3.59

65.01

4.7

2.1

—

(3027008) Opiates [Presence] in Urine

228

675

3.59

64.72

4.6

2.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

733

3939

2.17

64.20

4.1

2.9

e6/l

1.0

0.11

411

2294

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

203

563

3.81

63.43

2.1

1.7

—

(3008295) Osmolality of Serum or Plasma

129

251

5.34

63.13

1.5

1.4

mosm/kgh2o

283.0

280.5

0.37

183

(3028626) Oxygen [Partial pressure] in Capillary blood

250

802

3.33

62.56

15.2

5.0

kpa

8.3

8.7

3.07

233

753

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

144

6.94

62.46

1.8

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

193

524

3.88

62.15

2.1

1.8

e6/l

3686.1

1621.4

1.13

160

419

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

193

524

3.88

62.15

2.1

1.7

e6/l

81.2

28.9

0.79

155

403

(3011288) Drugs identified in Urine by Screen method

174

439

4.16

61.99

6.4

3.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

577

2865

2.28

61.08

2.0

1.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

148

334

4.62

60.86

7.0

4.8

umol/l

373.7

361.6

0.28

126

292

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

203

586

3.66

59.77

2.0

1.7

—

(3027945) Reticulocytes/100 erythrocytes in Blood

567

2823

2.27

59.47

3.0

2.7

2.0

1.8

4.04

493

2495

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

525

2539

2.32

58.96

2.5

1.8

1.5

10.17

411

2229

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

542

2658

2.29

58.89

3.9

4.2

u/l

254.4

251.0

0.18

518

2517

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

963

5879

1.98

58.65

2.7

2.2

mg/l

3.3

3.0

2.57

823

5000

(3002385) Erythrocyte distribution width [Ratio]

2259

18386

2.21

58.25

49.2

17.7

14.4

13.7

64.03

2221

17966

(3004451) EKG impression Narrative

108

7.60

56.07

1.6

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

439

2013

2.40

55.44

3.3

3.0

ng/l

363.0

216.8

4.43

408

1850

(3051651) Icteric interference index of Serum or Plasma

137

6.68

55.38

5.0

3.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

289

1082

2.86

55.17

1.9

1.8

g/l

1.6

1.5

1.45

251

922

(3016018) Differential panel - Cerebral spinal fluid

123

260

4.90

54.71

2.3

1.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

803

4765

1.96

51.93

2.8

1.8

mg/l

2.4

1.3

6.52

656

3641

(3015377) Calcium [Moles/volume] in Serum or Plasma

1122

7448

1.85

51.20

4.2

3.3

mmol/l

2.3

2.4

5.64

987

6487

(3028026) IgM [Mass/volume] in Serum or Plasma

324

1337

2.61

51.05

2.0

1.8

g/l

1.2

1.4

0.94

290

1231

(3012441) Differential panel - Pleural fluid

113

242

4.82

49.47

1.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

703

4048

1.99

49.20

3.8

3.0

mmol/l

2.5

6.78

539

3552

(3005719) IgG [Mass/volume] in Serum or Plasma

378

1706

2.41

49.11

3.4

2.8

g/l

9.9

10.5

1.43

340

1565

(3023410) Appearance of Cerebral spinal fluid

117

263

4.60

48.29

2.4

2.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

328

1398

2.53

48.22

1.7

1.4

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2096

17037

1.93

47.71

13.2

7.4

u/l

92.5

81.0

16.80

1998

16021

(3003181) Sodium [Moles/volume] in Urine

145

394

3.83

46.52

1.7

1.5

mmol/l

60.0

64.6

0.51

110

321

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

185

590

3.29

46.50

1.5

1.7

mg/l

1245.5

536.2

1.23

174

557

(3031040) Bacteria [#/volume] in Urine by Automated count

1859

14608

1.82

46.38

7.1

4.4

e6/l

611.8

1527.3

0.74

221

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1430

10420

1.77

46.14

7.0

4.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

725

4315

1.92

45.52

2.1

1.8

nmol/l

1170.9

1186.3

0.14

538

3258

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

109

6.75

45.50

1.9

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

153

440

3.62

45.17

1.7

1.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2785

0.17

44.71

6.6

7.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

101

216

4.81

44.28

3.3

3.7

—

(3003434) Protein [Mass/volume] in Pleural fluid

125

318

4.07

43.94

1.5

g/l

30.1

32.1

0.71

108

288

(3020630) Protein [Mass/volume] in Serum or Plasma

400

1947

2.23

43.25

2.9

2.7

g/l

63.7

66.3

7.28

371

1781

(3019977) pH of Arterial blood

119

6.27

42.97

7.6

3.0

7.4

0.06

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

141

403

3.63

42.00

1.7

1.5

—

(3000494) Fungus identified in Specimen by Culture

488

2600

2.06

41.70

2.1

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

110

270

4.20

40.56

2.7

6.9

mmol/l

6.9

7.3

0.80

225

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

119

310

3.97

40.49

1.8

1.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

401

2008

2.16

40.23

2.3

2.2

nmol/l

347.4

367.2

1.05

371

1836

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

151

465

3.38

40.10

9.6

5.8

iu/ml

5276.3

688.5

0.44

(3019225) pH of Specimen

2229

0.12

40.04

3.4

4.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

190

673

2.96

39.86

1.6

1.3

—

(3044889) 12 lead EKG panel

1905

15406

1.75

39.44

5.7

3.9

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

123

5.90

39.31

2.8

1.5

—

(4035726)

378

1874

2.18

38.81

1.6

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

229

4.40

38.52

5.1

3.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

238

984

2.55

37.00

3.0

2.0

ug/l

1.4

2.2

0.80

225

869

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1268

9300

1.67

36.94

4.4

2.8

ug/l

194.9

139.9

4.29

1151

8534

(40768806) Pleura Pathology biopsy report

100

246

4.18

36.77

1.6

1.5

—

(3045788) Cell count panel - Pleural fluid

228

4.28

36.08

1.6

1.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1002

6952

1.69

35.79

3.6

2.6

u/l

66.9

57.5

1.69

932

6408

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

136

5.33

35.33

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

6.78

34.42

2.0

—

(3042631) Mycobacterium sp identified in Specimen

111

310

3.69

34.20

2.4

2.8

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

179

4.63

34.15

1.3

1.2

mmol/l

2.8

2.0

2.62

169

(3017569) Oxygen content in Arterial blood

6.13

34.10

5.7

2.5

—

(3042517) Benzodiazepines panel - Urine

16.27

34.05

2.3

1.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

799

5274

1.72

33.96

1.8

1.6

nmol/l

19.6

20.3

0.73

720

4502

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

122

368

3.42

33.46

7.2

3.5

u/ml

41706.3

1993.0

0.51

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

109

311

3.61

32.54

1.8

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

107

5.71

32.25

2.8

2.2

umol/l

56.4

52.4

0.38

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

129

417

3.20

31.65

2.0

1.5

u/ml

108.1

116.6

0.25

(3042733) HLA Ab [Presence] in Serum

6.56

31.54

4.5

4.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

116

353

3.39

31.38

1.8

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

815

5506

1.68

31.31

3.8

2.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

291

1412

2.18

31.25

2.3

1.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

113

341

3.41

30.97

1.2

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

6.29

30.89

2.7

2.6

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

108

5.56

30.85

16.7

10.8

mmol/l

0.6

0.05

100

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

193

787

2.56

30.79

2.1

2.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1216

9102

1.60

30.75

2.4

2.0

pmol/l

86.4

94.2

8.39

646

4847

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

14.13

30.51

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

176

4.41

30.24

1.2

titre

78.1

170.9

0.97

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

172

4.45

30.21

2.1

1.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

329

1695

2.07

30.19

6.2

4.3

ng/l

121.3

92.1

3.85

284

1484

(3020891) Body temperature

213

921

2.42

29.96

9.5

4.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

165

634

2.70

29.66

2.3

g/l

0.0

0.00

145

586

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

147

532

2.86

29.60

1.4

1.6

mmol/l

3.9

3.8

0.82

132

498

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

133

457

3.01

29.40

2.0

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

165

640

2.68

29.11

2.3

g/l

0.0

0.00

145

587

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

171

685

2.59

28.27

2.3

g/l

0.1

0.0

0.45

151

629

(3007566) Smooth muscle Ab [Titer] in Serum

152

574

2.74

28.25

1.3

1.2

titre

171.4

92.4

0.63

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

16.13

28.01

5.4

7.5

—

(3016038) Potassium [Moles/volume] in Urine

162

4.41

27.89

1.4

1.3

mmol/l

39.4

34.1

0.84

147

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

113

365

3.18

27.77

8.5

3.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

231

3.76

27.28

1.3

1.4

mmol/l

6.9

6.5

0.54

216

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

130

464

2.89

26.85

2.0

1.5

u/ml

23.5

19.0

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

923

6649

1.58

26.41

3.7

3.1

ng/l

3644.4

1580.2

6.92

773

5694

(3037467) Urinalysis macro (dipstick) panel - Urine

1821

15253

1.56

26.18

6.5

4.3

—

(3047181) Lactate [Moles/volume] in Blood

173

724

2.48

26.10

16.9

7.0

mmol/l

1.4

1.3

0.40

124

626

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1867

21226

0.63

26.03

4.4

mmol/l

1.3

1.4

22.48

1663

19503

(40761539) Cells [Type] in Urine sediment by Light microscopy

6.86

25.90

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

6.45

25.63

1.8

1.2

40.2

17.7

1.54

(3023199) Leukocytes [#/volume] in Pleural fluid

292

3.33

25.32

1.5

1.4

e6/l

962.7

1738.0

2.96

211

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

181

787

2.39

25.11

2.4

g/l

1.3

1.2

0.06

154

682

(3028308) Erythrocytes [#/volume] in Pleural fluid

259

3.48

25.10

1.5

1.4

e6/l

43007.0

100180.0

0.79

157

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1893

21394

0.64

24.67

4.5

4.4

mmol/l

4.3

4.6

17.91

1712

19785

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

5.49

23.84

3.5

2.7

umol/l

31.2

30.5

0.06

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

166

714

2.41

23.58

2.3

2.2

g/l

34.7

37.7

6.37

147

615

(3007164) IgA [Mass/volume] in Serum or Plasma

625

4228

1.62

22.72

1.8

1.5

g/l

2.7

2.5

1.60

375

2526

(3034860) Kappa light chains.free [Mass/volume] in Serum

169

752

2.33

22.23

2.9

3.5

mg/l

104.5

60.9

0.42

104

607

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

168

751

2.32

21.87

3.0

3.5

mg/l

59.5

71.9

0.26

103

607

(3004588) Protein electrophoresis panel - Serum or Plasma

294

1626

1.90

21.75

2.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

115

431

2.74

21.71

1.8

1.4

u/ml

324.4

262.7

1.17

251

(3022493) Free Hemoglobin [Mass/volume] in Plasma

4.91

21.55

4.7

6.1

mg/l

3505.3

71.1

0.49

(3023520) Reticulocytes [#/volume] in Blood

356

2098

1.80

21.50

3.3

2.7

e9/l

75.5

68.8

1.90

227

1583

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1111

8618

1.48

21.32

5.4

3.7

ng/l

55.6

57.4

0.08

882

6132

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

163

730

2.31

21.13

3.0

3.5

ratio

2.7

1.8

0.41

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

173

797

2.25

20.97

2.9

3.4

u/ml

134.5

5408.1

0.89

150

684

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

106

393

2.76

20.44

1.2

—

(40761535) Cells panel - Urine sediment

1891

0.31

20.41

4.2

3.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

118

4.38

20.38

5.7

2.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1967

21834

0.66

20.18

5.2

4.9

mmol/l

2.5

2.7

20.16

1769

20077

(3009445) Proteinase 3 Ab [Units/volume] in Serum

195

957

2.12

20.18

1.9

1.5

u/ml

11.3

19.2

0.39

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1679

14206

1.46

19.96

5.4

3.2

u/l

80.7

51.8

11.59

1570

13201

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

147

3.94

19.75

1.3

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

208

3.43

19.73

1.2

u/l

72.8

60.5

0.48

144

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

295

1688

1.84

19.55

13.5

4.5

mmol/l

2.9

1.6

7.02

203

1210

(40760888) Immunoglobulin light chains.free panel - Serum

134

572

2.41

19.37

2.8

3.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

115

457

2.58

19.35

1.8

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

148

662

2.31

19.24

1.7

1.4

ug/g

247.2

279.2

0.95

391

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1768

0.31

19.06

1.7

1.8

—

(40768797) Stomach Pathology biopsy report

457

2978

1.64

18.98

1.4

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

125

4.14

18.93

1.7

1.5

u/l

5.8

7.0

0.20

(44790047)

297

2.96

18.91

1.8

1.6

—

(44790049)

297

2.96

18.91

1.8

1.6

—

(44790048)

297

2.96

18.91

1.8

1.6

—

(44806118)

297

2.96

18.91

1.8

1.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

177

861

2.13

18.73

2.5

2.4

g/l

3.6

3.1

9.63

147

678

(3036525) Urea [Moles/time] in 24 hour Urine

14.25

18.49

3.8

—

(3022217) INR in Platelet poor plasma by Coagulation assay

466

3071

1.62

18.46

31.1

26.9

inr

1.3

1.4

0.45

426

(3025159) Blasts/100 leukocytes in Blood

287

1663

1.81

18.22

5.5

4.2

0.0

0.3

0.84

116

441

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

348

2.76

18.20

2.1

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

101

389

2.66

18.11

1.8

1.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

176

3.52

18.00

2.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

260

1468

1.85

17.95

18.6

7.2

mmol/l

25.7

24.4

3.96

240

1361

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1109

8811

1.43

17.79

3.1

2.3

nmol/l

72.2

76.8

5.28

1001

7867

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

298

1762

1.77

17.66

13.4

4.5

kpa

5.2

5.1

2.39

279

1642

(3009343) pH of Capillary blood

295

1742

1.78

17.56

13.7

4.5

7.4

0.12

134

176

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

4.44

17.54

1.5

1.4

57.5

63.2

0.43

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

5.55

17.43

2.0

2.4

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

42.26

17.28

1.0

mmol/l

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

181

918

2.04

17.15

2.6

2.4

g/l

4.1

3.8

0.66

147

661

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

181

919

2.04

17.09

2.6

2.4

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

4.80

17.06

1.6

1.5

5.2

2.3

0.74

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

181

920

2.03

17.04

2.6

2.4

g/l

7.9

7.4

2.53

147

695

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

219

1191

1.91

16.97

2.7

3.3

pmol/l

4.2

4.5

3.63

191

1052

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

7.20

16.95

10.7

12.3

mmol/l

4.4

6.4

2.81

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

350

2.68

16.92

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

171

859

2.06

16.63

2.5

2.4

g/l

9.9

10.4

0.74

151

729

(3025941) Bacteria identified in Stool by Culture

213

1156

1.91

16.61

1.4

1.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

171

3.44

16.59

1.3

u/l

10.9

14.4

0.68

158

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

181

3.37

16.56

2.3

9.8

12.7

0.84

102

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

333

2069

1.69

16.49

2.2

2.4

ug/l

12.1

7.4

1.23

294

1813

(3009508) Creatinine [Moles/volume] in Urine

917

7114

1.43

16.44

4.4

3.3

mmol/l

6.8

7.7

6.37

743

5997

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

359

2277

1.66

16.44

3.8

4.2

ug/l

16.6

24.4

0.37

294

1874

(3039000) Anion gap in Blood

119

520

2.35

16.35

22.0

8.3

mmol/l

10.6

11.4

1.70

100

455

(3002179) Metamyelocytes/100 leukocytes in Blood

285

1700

1.75

16.35

5.3

3.9

0.7

0.6

0.28

112

411

(3018572) Chloride [Moles/volume] in Blood

119

521

2.34

16.28

22.0

8.3

mmol/l

106.3

105.5

0.81

100

456

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

104

4.18

16.27

1.8

1.2

54.5

65.7

0.57

(3010375) cycloSPORINE [Mass/volume] in Blood

104

4.18

16.27

37.2

28.3

ug/l

123.1

128.8

0.20

(3011648) Oxygen content in Venous blood

214

3.13

16.21

2.7

4.0

10.9

11.1

0.11

214

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1846

20517

0.70

16.19

4.3

4.0

mmol/l

1.5

1.3

13.72

1643

18730

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

114

4.00

16.02

1.2

u/l

43.1

19.5

1.15

(3024980) IgG subclass 4 [Mass/volume] in Serum

337

2.66

15.99

1.3

1.7

g/l

0.5

0.9

3.77

262

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

333

2.66

15.83

1.3

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

141

673

2.15

15.68

1.7

1.3

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

208

3.13

15.67

1.3

g/l

1.8

2.8

6.25

148

(3018851) Theophylline [Moles/volume] in Serum or Plasma

9.10

15.55

2.4

1.5

umol/l

52.7

49.0

0.11

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

954

0.16

15.39

1.6

1.9

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

165

3.38

15.33

1.5

1.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1169

0.25

15.06

1.6

1.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

208

3.08

15.03

1.3

g/l

5.4

6.9

2.21

148

(3024139) IgG subclass 3 [Mass/volume] in Serum

208

3.08

15.03

1.3

g/l

0.3

0.4

0.82

149

(3024471) HLA-A [Type]

4.49

14.94

1.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

6.53

14.92

1.4

1.7

13.2

4.3

1.51

(3007930) Methemoglobin/Hemoglobin.total in Blood

175

924

1.95

14.80

17.3

6.0

0.9

0.12

154

855

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

130

615

2.17

14.80

1.6

1.4

g/l

0.2

0.47

116

584

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

121

3.76

14.77

1.2

1.1

u/l

215.9

93.0

0.73

105

(3037522) Nuclear Ab [Titer] in Serum

405

2723

1.57

14.50

1.4

1.3

titre

393.1

495.5

0.60

561

(3035880) pH of Pleural fluid

137

3.55

14.45

1.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

7.29

14.40

1.2

—

(21494755) Public health laboratory ask at order entry panel

1795

0.40

14.36

1.3

—

(3017181) Myelocytes/100 leukocytes in Blood

300

1880

1.67

14.32

5.5

4.1

1.1

0.8

0.98

125

577

(4062490)

210

3.00

14.18

1.3

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

102

3.96

14.14

3.1

4.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1921

21076

0.71

14.13

4.8

4.6

mmol/l

6.3

6.0

8.64

1690

19127

(3001964) Herpes simplex virus Ag [Presence] in Specimen

4.81

14.01

1.3

1.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

131

639

2.10

13.80

1.7

1.4

g/l

1.2

0.02

117

604

(3043410) Blood group antigens tested for on Red Blood Cells

4.61

13.76

2.5

1.9

—

(3021440) Promyelocytes/100 leukocytes in Blood

284

1776

1.67

13.65

5.6

4.2

0.1

0.40

120

525

(40768446) Kidney Pathology biopsy report

105

3.85

13.60

2.6

1.6

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.80

13.54

1.3

1.4

—

(3024932) HLA-DR beta [Type]

4.29

13.37

1.0

1.1

—

(3033799) Differential panel - Peritoneal fluid

4.60

13.29

3.5

2.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

869

0.19

13.12

1.5

1.8

—

(21494814) CD8 cells/100 lymphocytes in Specimen

4.33

13.12

1.9

2.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.62

12.89

10.8

5.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

190

2.99

12.80

1.3

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

9.42

12.55

4.9

1.9

44.9

59.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

103

475

2.21

12.53

3.6

3.1

nmol/l

0.9

0.8

0.55

363

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

5.25

12.48

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

4.34

12.40

2.4

2.1

nmol/l

147.6

145.6

0.05

(3004119) Hemoglobin [Mass/volume] in Venous blood

236

1441

1.70

12.40

4.7

3.6

g/l

121.5

128.4

4.29

228

1399

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

10.05

12.23

4.7

1.8

18.1

17.6

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

168

933

1.85

12.21

17.0

6.0

1.7

1.6

0.30

147

863

(3037692) Legionella sp identified in Specimen by Organism specific culture

4.23

11.98

1.1

1.5

—

(3000492) Spirometry study

307

2020

1.58

11.98

1.8

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

409

2.27

11.80

1.9

1.5

—

(3011412) CD3 cells [#/volume] in Blood

233

2.70

11.77

2.3

2.4

e9/l

1.4

1.2

0.59

140

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

12.05

11.74

6.3

5.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

12.05

11.74

6.5

5.0

—

(3000012) Reticulocyte production index

117

3.45

11.66

1.6

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

125

639

2.00

11.64

1.8

1.5

mu/l

403.9

286.5

1.66

105

588

(3000093) Morphology [Interpretation] in Blood Narrative

224

2.72

11.54

1.4

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

581

7493

0.72

11.22

3.4

4.3

21.3

21.7

0.24

230

3673

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

4.93

11.20

1.2

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

730

5743

1.37

11.18

5.7

3.3

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

5.56

11.17

2.0

2.2

umol/l

13.9

19.5

1.33

(3009542) Hematocrit [Volume Fraction] of Blood

2193

20247

1.39

11.14

44.9

15.7

37.9

39.7

24.76

1662

14292

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

10.95

11.06

3.3

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

7.93

11.01

1.7

1.4

mg/l

1.8

7.2

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

7.93

11.01

1.7

1.4

mg/l

0.3

1.5

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

7.93

11.01

1.7

1.4

mg/l

0.8

2.4

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

7.93

11.01

1.7

1.4

mg/l

3.0

4.8

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

7.93

11.01

1.7

1.4

mg/l

1.0

2.0

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

7.93

11.01

1.7

1.4

mg/l

0.4

1.3

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

7.93

11.01

1.7

1.4

mg/l

0.5

2.9

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

7.93

11.01

1.7

1.4

mg/l

2.5

2.3

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

5.59

10.69

2.3

2.6

—

27.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

332

2.33

10.56

1.3

1.2

u/ml

2.8

3.3

0.20

112

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

7.54

10.56

1.7

1.4

mg/l

0.6

2.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

1250

10699

1.31

10.54

6.6

4.9

estimate

0.0

0.50

471

2024

(40760892) CBC W Ordered Manual Differential panel - Blood

615

4749

1.38

10.49

7.3

4.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

142

3.06

10.35

1.7

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

1247

10694

1.30

10.27

5.1

3.6

estimate

0.0

0.00

474

1979

(3046861) Legionella sp Ag [Presence] in Urine

11.04

10.16

1.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

205

2.67

10.10

1.2

—

(4281824)

184

2.75

9.93

1.3

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

9.27

9.87

1.4

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

121

3.17

9.73

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

371

2.19

9.68

1.4

1.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.86

9.67

8.4

2.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.86

9.67

8.4

2.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

771

9361

0.76

9.58

3.8

5.0

ug/l

3.4

3.1

0.11

648

8380

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

321

2.28

9.58

1.3

1.2

u/ml

3.7

5.2

0.60

140

(3009261) Glucose [Presence] in Urine by Test strip

1254

10834

1.29

9.49

5.1

3.6

estimate

0.0

0.02

455

1934

(3026480) Teichoate Ab [Titer] in Serum

7.03

9.28

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

7.03

9.28

1.5

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

3.56

9.22

2.7

2.2

e6/l

1231.1

380.6

0.39

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

105

3.27

9.16

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

296

2.29

9.12

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

152

899

1.73

9.00

1.1

u/ml

—

1.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

6.28

8.99

1.3

2.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

5.51

8.97

1.6

3.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

128

3.00

8.88

1.4

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

128

3.00

8.88

1.4

1.6

—

(3044007) Cell count panel - Peritoneal fluid

3.93

8.86

2.0

2.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

320

2.22

8.80

1.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

116

638

1.85

8.77

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

270

2.33

8.74

1.8

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

157

2.77

8.71

1.1

1.2

—

(3016750) Collection duration of Urine

147

2.82

8.59

2.4

2.1

min

486.1

493.5

0.14

106

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

286

2.27

8.50

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

116

647

1.83

8.40

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

3.76

8.34

1.7

1.5

g/l

9.9

12.9

0.94

(3006245) CD3-CD19+ cells/100 cells in Blood

112

3.06

8.27

3.2

2.4

9.9

13.1

0.44

106

(3020393) Adenovirus Ag [Presence] in Stool

3.92

8.15

3.5

1.6

—

(3006653) Thiamine [Moles/volume] in Blood

114

3.01

8.04

1.1

1.3

nmol/l

139.4

140.7

0.04

114

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

113

636

1.81

7.96

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

913

0.39

7.95

1.7

—

(3010813) Leukocytes [#/volume] in Blood

2361

24631

0.73

7.88

55.0

21.5

e9/l

7.8

6.8

51.65

2291

23861

(3000963) Hemoglobin [Mass/volume] in Blood

2361

24630

0.73

7.86

55.9

21.6

g/l

125.1

135.6

141.22

2319

24246

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

239

2.33

7.82

1.2

1.1

89.5

94.9

0.59

225

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

531

1.88

7.80

1.3

miu/ml

247.4

225.2

0.17

228

(3026361) Erythrocytes [#/volume] in Blood

2361

24625

0.73

7.78

54.8

21.4

e12/l

4.2

4.5

99.59

2288

23855

(3035941) MCH [Entitic mass]

2361

24623

0.73

7.75

54.7

21.3

30.2

30.3

2.07

2319

24239

(3024731) MCV [Entitic volume]

2361

24622

0.73

7.74

54.7

21.4

91.6

90.9

7.37

2319

24240

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

312

2.14

7.68

1.2

1.1

110.9

114.6

0.32

285

(3007461) Platelets [#/volume] in Blood

2360

24609

0.73

7.67

54.8

21.4

e9/l

252.0

246.1

3.01

2297

23922

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

520

1.88

7.65

1.3

1.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

6.69

7.60

1.3

1.1

—

(4306422)

315

2.12

7.51

1.3

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

246

2.26

7.34

1.1

1.2

—

(3017509) Phencyclidine [Presence] in Urine

6.34

7.24

3.0

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

313

2.10

7.24

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

115

1898

0.59

7.21

1.5

—

(3038026) Centromere Ab [Units/volume] in Serum

178

0.00

7.21

0.0

1.1

—

56.8

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

187

2.43

7.10

1.1

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

5.67

7.06

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

472

0.21

6.99

1.8

1.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

3.40

6.97

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

3.70

6.91

1.4

1.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.06

6.89

1.3

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

172

0.00

6.84

0.0

1.1

—

37.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

228

2.26

6.84

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

173

0.00

6.82

0.0

1.1

—

59.2

—

(3003694) ABO and Rh group [Type] in Blood

731

6101

1.27

6.76

1.7

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.27

6.75

1.7

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

117

705

1.69

6.56

1.6

1.4

iu/l

26.4

26.9

0.05

577

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

3.26

6.55

1.0

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

312

2.04

6.55

2.3

2.7

u/ml

4502.5

186.0

0.62

297

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

162

0.00

6.50

0.0

1.1

—

4.5

—

(3037756) Immunofixation for Serum or Plasma

500

1.81

6.38

1.4

1.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.91

6.31

1.4

1.2

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

18.05

6.26

1.0

u/field

2.0

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

239

2.16

6.14

2.4

2.5

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

5.81

6.10

1.4

1.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

709

5963

1.25

6.04

3.5

2.8

umol/l

1400.3

5409.3

4.60

584

5192

(3014891) Appearance of Pleural fluid

4.30

6.02

1.8

1.5

—

(1761868) Lipid panel - Serum or Plasma

621

7406

0.79

6.00

3.2

2.9

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

100

2.82

5.99

1.1

u/ml

—

14.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.83

5.97

1.2

1.5

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

165

2.38

5.97

1.4

1.5

umol/l

15.0

12.9

0.73

156

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.69

5.92

1.2

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

15.04

5.90

1.2

1.0

—

(3012516) Albumin [Mass/volume] in Urine

782

6665

1.24

5.89

3.9

3.3

mg/l

478.6

332.3

0.42

549

4367

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

179

2.31

5.85

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

175

2504

0.68

5.77

1.5

1.4

—

(3011985) Renin [Units/volume] in Plasma

266

2.05

5.74

1.4

mu/l

71.6

62.1

0.22

230

(3017732) Neutrophils [#/volume] in Blood

1487

0.59

5.70

4.1

3.2

e9/l

4.6

4.2

0.61

1149

(3005322) IgE [Units/volume] in Serum or Plasma

190

1326

1.46

5.66

1.3

u/ml

278.3

232.9

0.29

175

1226

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2323

22185

1.28

5.59

41.2

14.6

mg/l

33.8

25.3

25.05

2153

17650

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

12.89

5.58

12.1

7.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

514

0.33

5.56

1.9

1.6

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.83

5.53

2.4

2.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

128

2.52

5.53

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

128

2.52

5.53

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.25

5.52

3.3

3.8

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

768

0.45

5.51

2.3

1.7

mg/l

6.8

4.1

0.44

542

(3019832) Treponema pallidum Ab [Presence] in Serum

223

1618

1.41

5.40

1.8

1.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

474

1.75

5.39

3.7

3.5

u/ml

898.4

894.5

0.00

446

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

180

2.24

5.35

2.2

u/field

2.4

1.9

0.21

(3021788) Differential panel - Synovial fluid

394

1.82

5.35

1.5

1.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

261

2.01

5.28

1.6

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.84

5.24

1.1

miu/ml

1667.8

1606.6

0.12

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

144

2.38

5.23

1.8

2.8

39.0

37.1

0.23

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.24

5.17

1.3

1.4

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

13.37

5.08

8.6

5.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

13.37

5.08

1.8

1.0

—

(3004775) Volume in Urine collected for unspecified duration

191

2.16

5.07

2.5

2.3

663.2

636.7

0.12

123

(3045142) Bone marrow Pathology biopsy report

266

1.97

5.03

1.7

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

683

5822

1.23

5.02

6.3

3.9

estimate

0.0

1.28

417

1918

(3044941) Cell count panel - Synovial fluid

359

1.83

5.00

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1904

20132

0.83

4.91

6.8

5.8

mmol/mol

41.5

40.1

5.73

1751

18602

(3006922) Hepatitis E virus Ab [Presence] in Serum

136

2.37

4.90

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

114

740

1.56

4.83

1.8

1.7

—

(40757373) Influenza virus identified in Isolate

3.17

4.76

1.4

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

601

1.62

4.73

1.5

1.6

—

(3002256) Pathology report gross observation

357

2844

1.29

4.68

1.4

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

662

5692

1.21

4.40

1.7

mmol/l

1.7

1.4

5.93

542

4758

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

2.89

4.33

1.1

1.3

nmol/l

91.8

125.4

0.37

(3034426) Prothrombin time (PT)

2.89

4.33

1.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

107

2.44

4.30

1.2

1.1

u/l

75.6

32.6

0.77

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

227

1.95

4.21

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

2.75

4.18

2.0

2.3

e6/l

17717.1

24033.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

263

1.88

4.17

1.8

1.3

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.92

4.17

1.8

mmol/l

0.8

1.4

0.84

(40759836) Histone Ab [Presence] in Serum by Immunoblot

147

2.19

4.14

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

147

2.19

4.14

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

147

2.19

4.14

1.1

—

(4212803)

4.36

4.09

1.2

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.76

4.08

1.2

1.4

—

(21494434) Karyotype in Bone marrow

237

1.91

4.06

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.57

4.05

2.1

2.6

e6/l

443.2

801.0

0.65

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

104

0.00

4.01

0.0

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

104

0.00

4.01

0.0

1.4

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

10.02

4.01

1.0

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

3.94

3.97

7.1

4.4

mg/l

1.6

2.1

0.47

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

150

2.15

3.96

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

150

2.15

3.96

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

150

2.15

3.96

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.82

3.95

1.1

1.2

ug/l

359.4

171.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

142

1009

1.43

3.93

1.3

—

(3019150) Specific gravity of Urine by Refractometry

391

4709

0.80

3.93

5.3

3.9

kg/l

1.0

0.21

717

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

144

2.17

3.92

2.5

1.9

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

593

1.55

3.86

1.7

1.5

u/l

9.5

8.4

0.26

457

(3020682) Albumin/Creatinine [Ratio] in Urine

794

7017

1.18

3.85

5.3

4.0

mg/mmol

30.9

12.0

4.21

517

4560

(36660697) Celiac disease serology panel - Serum

222

1704

1.33

3.84

1.1

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

100

0.00

3.83

0.0

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

3.19

3.77

1.7

1.4

—

(3011325) HIV 1+2 Ab [Presence] in Serum

8.77

3.77

1.0

—

(3002619) Bacteria identified in Specimen by Culture

3.26

3.62

1.2

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1729

16292

1.16

3.57

4.4

3.8

pmol/l

14.6

14.8

4.01

1556

14727

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

249

1.82

3.54

1.4

pmol/l

253.6

289.1

0.36

188

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

702

0.55

3.50

1.9

1.8

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

287

1.76

3.49

1.8

1.3

nmol/l

0.2

0.4

—

(3049717) Cytology report of Urine Cyto stain

134

966

1.41

3.46

2.2

2.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

226

0.31

3.45

1.6

1.4

u/l

27.7

22.6

—

185

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

252

1.80

3.41

1.7

1.3

nmol/l

—

(4268621)

216

1.86

3.40

2.6

2.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

576

0.52

3.35

3.8

4.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.63

3.30

7.5

8.4

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

8.59

3.26

1.3

1.1

—

(3025315) Body weight

4.75

3.23

6.1

3.7

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.51

3.21

1.4

1.3

97.4

87.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

584

5100

1.18

3.19

3.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

218

0.32

3.18

3.0

1.5

—

(40768441) Liver Pathology biopsy report

151

2.00

3.14

1.7

1.4

—

(3022621) pH of Urine by Test strip

101

1421

0.70

3.13

2.8

2.9

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.48

3.12

1.3

1.0

84.9

88.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

180

1.90

3.09

2.4

2.3

e6/l

794.8

567.4

1.05

153

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

541

4710

1.18

3.06

1.3

u/ml

1.4

1.9

0.60

107

1190

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.69

3.05

1.1

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

5.84

3.02

1.1

1.0

—

(40768795) Lymph node Pathology biopsy report

190

1.85

2.97

1.1

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.64

2.96

7.9

8.8

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.47

2.95

1.3

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

0.00

2.93

0.0

1.1

—

6.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.34

2.90

1.0

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

236

1.75

2.89

1.1

—

(40768804) Tissue Pathology biopsy report

942

8592

1.15

2.88

2.3

2.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.51

2.87

1.2

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

6.68

2.87

2.7

1.9

—

(3000330) Specific gravity of Urine by Test strip

1117

0.68

2.84

2.6

3.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1196

0.69

2.81

32.2

4.9

mmol/l

24.6

24.5

0.09

1137

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.06

2.81

1.5

1.3

—

(4010399)

193

1524

1.29

2.78

1.5

1.4

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

3.92

2.77

13.8

10.3

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

8.35

2.75

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

8.35

2.75

1.8

1.2

—

(3025549) Creatine [Moles/time] in 24 hour Urine

5.01

2.73

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.37

2.72

1.3

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

2.43

2.71

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

198

1.78

2.64

1.5

—

(3020650) Glucose [Presence] in Urine

2.55

2.61

2.1

1.6

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

4.68

2.59

1.1

1.2

ng/l

10647.0

4884.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

362

1.56

2.57

1.2

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.04

2.52

1.1

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

129

1.95

2.50

2.4

2.1

ug/min

193.5

170.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

248

1.66

2.46

1.8

2.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

174

1.79

2.42

2.5

2.4

e9/l

0.2

0.22

152

(3048879) Bone marrow aspiration report

0.00

2.40

0.0

2.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.34

2.39

1.2

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.76

2.37

1.1

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.76

2.37

1.1

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.76

2.37

1.1

1.3

—

(3007463) Buprenorphine [Presence] in Urine

6.26

2.37

2.0

2.6

—

(3022313) Gas panel - Capillary blood

1328

0.74

2.36

28.8

4.6

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

4.13

2.36

1.1

—

(3045716) Anion gap in Serum or Plasma

111

1.99

2.35

3.1

2.5

mmol/l

12.1

9.3

0.86

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

568

1.42

2.35

1.8

2.0

mg/l

10.5

11.3

0.47

519

(3008757) Leukocyte morphology finding [Identifier] in Blood

290

0.45

2.32

3.6

4.0

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1701

16242

1.12

2.29

5.0

4.0

mm/h

18.7

12.3

28.92

1555

14992

(3050129) First trimester maternal screen panel - Serum or Plasma

430

0.55

2.24

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

285

0.45

2.23

1.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.10

2.22

1.2

1.3

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

5.56

2.21

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

150

1.81

2.20

3.9

2.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

218

1.66

2.18

2.9

2.6

umol/l

10.2

0.00

158

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.69

2.15

2.0

1.2

—

(4034850)

712

0.67

2.07

23.0

10.0

—

(3013466) aPTT in Blood by Coagulation assay

5.01

2.07

1.6

1.0

31.1

35.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.41

2.02

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

140

1.79

2.00

1.2

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

209

1739

1.22

1.98

2.2

1.9

—

(3050794) Legionella sp Ab [Presence] in Serum

3.34

1.96

1.4

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.08

1.96

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.76

1.93

1.3

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.76

1.93

1.3

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.76

1.93

3.5

7.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

540

1.38

1.92

2.4

2.3

u/l

2979.4

3805.1

0.17

222

(4027681)

135

1.78

1.91

1.4

1.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2336

22826

1.15

1.90

48.3

17.1

mmol/l

138.7

139.6

42.20

2282

22249

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

1.88

0.0

1.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.31

1.87

1.2

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

100

1.91

1.85

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.40

1.85

1.2

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

221

1.59

1.85

2.6

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

175

1.66

1.82

1.3

1.2

mg/l

50.1

43.3

0.31

143

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

523

0.65

1.79

1.6

1.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2339

22884

1.14

1.76

48.9

17.2

mmol/l

4.0

0.09

2278

22262

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

3.34

1.74

1.3

1.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

281

1.50

1.74

1.5

1.7

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

410

0.61

1.74

1.1

u/ml

0.3

1.5

2.22

232

(3003888) Timothy IgE Ab [Units/volume] in Serum

421

0.61

1.72

1.1

u/ml

1.0

5.1

4.36

255

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.85

1.71

1.2

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

3.85

1.71

1.0

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

1.70

0.0

5.7

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

1.70

0.0

2.8

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

118

1.79

1.70

1.1

1.2

ratio

1.2

1.1

2.95

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

154

1266

1.23

1.68

1.2

iu/ml

122.3

150.6

0.42

460

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

477

0.65

1.65

1.6

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

228

1.54

1.65

1.7

1.5

nmol/l

0.2

0.3

2.95

180

(3013336) Amino acids [Identifier] in Serum or Plasma

2.80

1.65

2.7

2.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

212

0.47

1.63

1.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

212

0.47

1.63

1.5

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

212

0.47

1.63

1.5

1.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

533

4847

1.12

1.63

2.0

1.7

pmol/l

26256176.0

26652189.8

0.01

438

4026

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

225

1924

1.18

1.63

2.5

2.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

3.58

1.61

6.4

2.1

mmol/l

4.8

4.4

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

3.58

1.61

7.4

3.9

—

(4094501)

604

0.69

1.61

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.50

1.59

1.0

1.2

—

(3005570) Glucose [Moles/volume] in Urine

223

0.49

1.59

2.7

2.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

249

0.52

1.59

1.5

1.3

mmol/l

7.5

7.4

—

176

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

106

1.80

1.58

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

3.00

1.58

1.2

1.4

—

(3022670) pH of Venous cord blood

3.00

1.58

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.00

1.58

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.70

1.58

2.0

2.8

u/field

0.6

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2297

23422

0.89

1.56

42.2

17.0

umol/l

88.7

79.9

7.64

2297

23412

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

116

933

1.25

1.56

1.7

1.9

u/l

36.7

38.4

0.41

817

(3033705) Calcium.ionized [Moles/volume] in Venous blood

273

0.55

1.56

2.0

2.4

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

122

1.73

1.54

1.4

1.2

u/l

230.1

431.8

0.98

111

(3023430) Cat dander IgE Ab [Units/volume] in Serum

272

0.55

1.54

1.1

u/ml

0.7

5.0

—

126

(3022145) Colonoscopy Study observation

272

2375

1.16

1.54

1.5

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

245

0.53

1.52

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.60

1.51

2.6

1.9

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

129

0.39

1.48

2.0

1.3

—

1.4

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.13

1.44

1.4

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

682

0.73

1.43

1.6

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.92

1.43

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.73

1.43

1.0

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.73

1.43

1.0

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.73

1.43

1.2

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

578

1.31

1.43

3.2

2.4

ug/min

104.7

99.9

0.04

361

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

493

5387

0.90

1.42

2.6

3.1

ug/l

0.7

0.8

0.20

330

3601

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.42

1.39

1.4

1.3

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

2.08

1.38

3.5

2.2

mmol/l

6.3

8.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

104

1.74

1.37

1.3

1.2

iu/ml

438.1

223.2

0.38

104

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2298

23391

0.90

1.34

18.9

10.4

u/l

34.1

26.8

3.14

2231

22519

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

116

952

1.23

1.34

2.4

1.9

—

(40762814) Titanium [Mass/volume] in Blood

0.00

1.33

0.0

2.2

—

2.9

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

393

1.36

1.33

1.2

u/l

58.7

45.5

0.25

344

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

658

1.27

1.30

1.8

1.6

iu/ml

0.1

9.4

0.50

130

(3014133) Dog dander IgE Ab [Units/volume] in Serum

293

0.61

1.28

1.1

u/ml

1.5

5.2

—

135

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

1.94

1.27

1.3

1.4

34.6

27.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

459

0.69

1.26

1.3

1.2

u/ml

0.2

2.3

4.79

250

(3051387) C reactive protein [Mass/volume] in Capillary blood

505

0.71

1.25

3.8

3.4

mg/l

22.3

27.8

0.60

316

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.82

1.25

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.17

1.21

7.5

10.9

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.17

1.21

1.3

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

324

0.65

1.20

1.8

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

586

1.27

1.19

1.3

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.88

1.18

1.1

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

392

0.69

1.16

1.1

u/ml

0.5

2.6

—

119

(3024869) Neuronal Ab [Presence] in Serum

2.05

1.15

1.0

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.34

1.12

1.4

1.3

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

2.34

1.12

1.3

83.9

74.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

167

1.50

1.12

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.26

1.10

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

168

1.49

1.09

1.0

1.1

mg/l

301.6

297.1

0.03

141

(3013293) Extractable nuclear Ab [Presence] in Serum

2.38

1.09

3.0

1.7

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.69

1.07

2.0

2.2

—

34570.8

—

(3037121) Protein [Mass/volume] in Urine

101

840

1.21

1.07

4.8

3.9

g/l

0.3

0.10

374

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

161

1.49

1.06

1.2

1.4

mmol/l

14.3

12.0

0.63

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

296

3269

0.89

1.06

1.3

1.2

u/ml

44.8

11.7

0.68

1261

(3013637) Mi-2 Ab [Presence] in Serum

1.96

1.03

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.96

1.03

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.96

1.03

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.96

1.03

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.27

1.03

1.0

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.92

1.02

1.2

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

529

1.25

1.00

1.4

1.7

e6/l

19705.1

14758.5

0.27

376

(3048689) Calprotectin [Mass/mass] in Stool

281

2542

1.12

1.00

2.5

2.4

ug/g

235.0

146.4

1.70

234

2032

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

123

1.55

0.99

1.3

1.2

—

(40768800) Prostate Pathology biopsy report

581

0.77

0.96

1.0

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.80

0.96

1.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

326

3554

0.91

0.93

1.6

1.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.72

0.92

1.2

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

152

0.59

0.88

3.2

1.5

g/l

0.7

0.9

—

152

(3047189) Immunofixation for 24 hour Urine

119

1.52

0.88

1.7

1.6

—

(4024509)

181

0.61

0.87

2.4

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

130

0.54

0.87

1.0

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2072

20348

1.07

0.87

38.2

13.7

ml/min/173m2

82.3

79.7

4.03

1867

16766

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

255

1.34

0.86

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

265

1.32

0.84

1.7

1.6

73.3

61.8

1.06

168

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2018

19816

1.07

0.82

5.4

4.5

mu/l

1.9

2.1

1.22

1840

18047

(3010144) Erythrocytes [#/volume] in Synovial fluid

213

0.66

0.81

1.1

1.3

e6/l

10813.0

106038.2

—

144

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.58

0.81

1.2

1.3

—

(3013512) EKG study

616

6494

0.93

0.80

4.2

3.9

—

(3008898) HLA-B27 [Presence]

663

0.81

0.80

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

0.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.79

0.0

4.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

492

1.22

0.79

1.5

1.9

iu/l

3.3

4.7

0.68

169

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.78

0.0

1.2

—

9.5

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.77

0.0

1.1

—

1.4

—

(3045414) Leukocytes [Presence] in Urine

941

0.85

0.76

1.9

—

(40768793) Breast Pathology biopsy report

381

0.76

0.75

1.2

1.3

—

(40768443) Skin Pathology biopsy report

107

930

1.16

0.75

1.3

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

316

1.27

0.73

1.5

1.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

398

1.24

0.72

4.0

3.5

1.2

1.5

0.42

312

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

248

1.29

0.68

1.7

1.8

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.67

0.68

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

119

0.59

0.67

1.6

1.4

nmol/l

1.3

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

366

1.23

0.66

1.1

iu/ml

6.2

90.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.57

0.65

1.2

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

103

1.46

0.65

1.5

1.4

0.8

3.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

348

0.77

0.63

2.2

1.6

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

138

1.38

0.62

1.1

nmol/l

1.4

5.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

101

0.59

0.62

1.2

1.1

—

(4211845)

104

0.58

0.62

1.0

3.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.59

0.61

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.60

0.61

1.3

1.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

262

1.26

0.61

1.3

—

(44813793)

138

0.65

0.60

1.1

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.48

0.60

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.58

0.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.58

0.0

2.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

158

1.33

0.57

2.0

1.4

—

73.7

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

130

1438

0.90

0.56

2.3

2.4

au/ml

21.4

25.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

851

8232

1.05

0.55

5.6

3.8

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

148

0.67

0.55

1.0

1.3

u/ml

4.9

4.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

100

1.40

0.51

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.50

0.51

1.2

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

490

1.17

0.51

1.9

nmol/l

1.2

0.8

0.79

413

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

744

1.13

0.50

2.2

1.8

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

530

0.85

0.49

1.6

1.2

u/ml

31.6

9.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

127

1.34

0.49

1.1

u/l

0.9

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

111

0.63

0.48

2.3

15.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1312

13392

0.96

0.47

3.6

2.9

—

(4133840)

1.40

0.45

1.3

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

166

1790

0.92

0.45

2.8

ml/min/173m2

51.5

64.6

3.62

726

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.65

0.42

2.2

2.0

—

(3006462) Nitrate [Presence] in Urine

0.64

0.42

1.0

3.1

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

0.41

0.0

1.1

—

0.2

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.40

0.0

1.1

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.2

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.7

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.40

0.0

1.2

—

(3001729) Color of Synovial fluid

0.00

0.40

0.0

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

205

1.22

0.39

1.7

1.4

15.6

28.9

1.60

128

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

148

0.74

0.38

1.7

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

159

0.75

0.38

1.0

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

147

0.75

0.37

1.7

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

322

0.84

0.37

1.0

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

116

0.69

0.37

1.0

1.1

—

4.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

216

2282

0.94

0.35

1.7

1.6

—

(3002523) Influenza virus A Ag [Presence] in Specimen

352

0.85

0.35

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

351

0.85

0.34

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.33

0.33

2.5

2.8

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.32

0.33

2.3

1.9

ug/l

27.2

374.7

0.66

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.68

0.33

1.3

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

325

0.86

0.30

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.23

0.29

1.1

1.5

—

(3045424) Erythrocytes [Presence] in Urine

353

0.88

0.27

1.9

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.70

0.26

1.2

—

(3044927) Protein electrophoresis panel - Urine

246

0.85

0.26

1.3

1.2

—

(42870560) Thyrotropin [Units/volume] in Cord blood

127

0.79

0.25

1.0

mu/l

10.5

9.2

—

104

(3000285) Sodium [Moles/volume] in Blood

1.28

0.23

1.0

1.1

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.3

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(3042951) Complement C1q Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

17.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

124

1303

0.95

0.21

1.2

1.3

au/ml

52.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

306

1.11

0.21

1.6

1.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

5.4

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.21

0.0

1.5

—

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

366

0.90

0.20

1.6

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

366

0.90

0.20

1.6

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

366

0.90

0.20

1.6

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

124

1181

1.05

0.20

2.7

2.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

111

0.81

0.20

6.8

6.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

115

0.78

0.20

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

365

0.90

0.20

1.6

1.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.20

0.19

2.2

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

395

0.91

0.19

1.6

1.5

—

(3043409) Potassium [Moles/volume] in Arterial blood

714

0.94

0.18

12.8

4.1

mmol/l

4.0

3.9

0.80

665

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

166

1.15

0.18

1.5

1.3

u/ml

0.2

0.8

0.68

(3014051) Protein [Presence] in Urine by Test strip

497

0.92

0.18

1.9

2.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

103

1080

0.95

0.17

1.1

1.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

205

1.12

0.17

1.0

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.18

0.16

1.4

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

0.75

0.15

6.0

2.6

—

(3028433) Virus identified in Specimen by Culture

1.15

0.15

1.2

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.11

0.15

1.3

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.10

0.15

1.6

1.5

—

(3025130) Human papilloma virus identified in Specimen

188

1.12

0.14

1.8

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

110

1142

0.96

0.13

4.1

3.5

mmol/l

25.3

25.0

0.36

102

1105

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

159

0.88

0.13

1.1

—

(3015183) Erythrocyte sedimentation rate

106

0.85

0.13

1.1

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

135

1393

0.97

0.12

1.3

1.2

—

(3005033) Fetal Nuchal fold Thickness US

297

1.08

0.12

1.6

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

298

1.07

0.11

1.6

1.4

—

(1002224) Polysomnography panel

838

1.04

0.11

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

526

0.95

0.11

2.0

1.9

pmol/l

180.7

204.7

0.87

497

(3017704) Immunofixation for Urine

146

0.89

0.10

1.0

1.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

194

1981

0.98

0.10

2.4

2.2

nmol/l

11.6

12.9

1.33

151

1735

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.06

0.09

1.4

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

288

0.94

0.08

1.0

u/ml

6.6

2.6

—

112

(40761511) CBC panel - Blood by Automated count

2302

22968

1.01

0.08

35.8

13.8

—

(3003338) MCHC [Mass/volume]

1882

18760

1.01

0.08

48.5

18.9

g/l

329.6

332.9

37.04

1854

18604

(3024263) Appearance of Synovial fluid

117

1.11

0.08

1.7

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

709

1.03

0.07

1.7

—

(3035933) Granulocytes/100 leukocytes in Blood

0.84

0.06

4.8

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

150

0.93

0.04

1.1

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

161

1.06

0.03

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

138

0.94

0.02

1.5

1.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

158

0.95

0.02

1.0

1.1

iu/ml

16.7

6.8

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

591

1.02

0.02

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

343

3421

1.00

0.01

1.3

iu/ml

62.4

33.0

0.75

1051

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

136

0.96

0.00

1.5

1.3

—

(3006598) pH of Arterial cord blood

1.01

0.00

1.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

619

1.00

0.00

2.2

1.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

128

1.02

0.00

4.3

3.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

586

1.01

0.00

1.2

1.3

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.0

2.2

—

1184.4

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.6

—

2984.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.9

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.92

0.00

2.7

1.3

ug/l

15.6

9.3

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.0

2.2

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.0

—

7.8

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.98

0.00

3.6

2.7

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3013931) Oligosaccharides [Presence] in Urine

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

2.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.93

0.00

2.0

2.1

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(40765096) Chromosome analysis panel by Banding

0.95

0.00

1.1

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.0

—

2.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.01

0.00

1.1

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint INV_VENT and mortality.

Females

Parameter	HR [95% CI]	p-value
INV_VENT	5.323 [4.52, 6.27]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.054

During the follow-up period (1.1.1998 — 31.12.2019), 1935 out of 6835 females with INV_VENT died.

Males

Parameter	HR [95% CI]	p-value
INV_VENT	5.075 [4.37, 5.89]	< 0.001
Birth year	0.983 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 3468 out of 10146 males with INV_VENT died.

Mortality risk

Mortality risk for people of age

years, who have INV_VENT.

N-year risk	Females	Males
1	0.509%	0.916%
5	2.475%	5.381%
10	6.644%	12.904%
15	12.336%	22.399%
20	20.436%	34.488%

Relationships between endpoints

↥

Index endpoint: INV_VENT – Invasive ventilation

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Invasive ventilation

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints